Development and Characterisation of Valsartan Immediate Release Dosage Form Using Solubility Enhancement Technique
The objective of the present investigation is to improve the solubility of valsartan and prepare immediate release tablets.
Saved in:
Main Authors: | Saripilli R. (Author), Teella P. (Author), Nataraj Kalakonda S. (Author) |
---|---|
Format: | Book |
Published: |
Sciendo,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation and Characterization of Itraconazole as Nanosuspension Dosage Form for Enhancement of Solubility
by: Asmaa M. Rashid, et al.
Published: (2019) -
Biowaiver for Immediate and Modified Release Dosage forms Scientific summary of the CSPS workshop
by: Raimar Loebenberg
Published: (2020) -
Solubility enhancement of glimperide: Development of solid dispersion by solvent melt method, characterization and dosage form development
by: Kamla Pathak, et al.
Published: (2017) -
Solubility enhancement of glimperide: Development of solid dispersion by solvent melt method, characterization and dosage form development
by: Kamla Pathak, et al.
Published: (2017) -
HPLC method development for the simultaneous analysis of amlodipine and valsartan in combined dosage forms and in vitro dissolution studies
by: Mustafa Çelebier, et al.
Published: (2010)